
Europe CRISPR & Cas Genes Market Size, Share, Trends, Industry Analysis Report By Product (Kits & Enzymes, Libraries), By Service, By Application, By End Use, By Country – Market Forecast, 2025–2034
Description
The europe CRISPR & cas genes market size is expected to reach USD 7.25 billion by 2034, according to a new study by Polaris Market Research. The report “Europe CRISPR & Cas Genes Market Size, Share, Trends, Industry Analysis Report By Product (Kits & Enzymes, Libraries), By Service, By Application, By End Use, By Country – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.
CRISPR-Cas genes refer to a natural bacterial defense system used for gene editing. The CRISPR sequences guide the Cas enzyme to specific DNA locations to make precise cuts.
Europe is witnessing a steady rise in demand for precision medicine, which focuses on customized treatment based on an individual’s genetic profile. CRISPR plays a critical role in enabling these personalized therapies, especially for rare genetic disorders, cancers, and inherited diseases. Healthcare systems are investing more in genetic diagnostics and targeted treatments with aging populations and increasing rates of chronic illness. European hospitals and research centers are increasingly incorporating CRISPR into clinical research and early trials. This growing focus on tailored medical solutions positions healthcare as a key application area driving CRISPR adoption across Europe.
While Europe has historically maintained strict regulations on genetic modifications, recent discussions at both national and EU levels show growing openness to gene-editing technologies such as CRISPR. Proposals for separate regulatory treatment of precision-edited organisms signal a shift toward acceptance. These evolving regulatory frameworks are crucial in reducing entry barriers for developers and encouraging investment in CRISPR research. Stakeholders gain confidence as the legal landscape becomes clearer and more favorable, especially for agricultural and medical uses.
Europe CRISPR & Cas Genes Market Report Highlights
The kits and enzymes segment is projected to register a CAGR of 18.9% during the forecast period, driven by growing adoption in pharmaceutical development, academic research, and agricultural biotechnology.
The agricultural application segment held 12.45% of the total market revenue in 2024, supported by rising demand for sustainable farming practices and innovations aimed at enhancing global food security.
In 2024, Germany contributed 23.30% to the Europe CRISPR & Cas genes market, owing to its advanced biotech infrastructure, consistent government R&D investments, and strong industry-academic partnerships.
France accounted for 15.98% of the Europe CRISPR & Cas genes market in 2024, backed by strategic funding in genomics, biotechnology advancements, and increasing focus on agricultural gene-editing research.
A few key market players are AstraZeneca, Caribou Biosciences, Inc., CRISPR Therapeutics, Danaher Corporation, Editas Medicine, Inc., Horizon Discovery Group Plc, Merck KGaA, New England BioLabs, Oxford Genetics Limited, Sherlock Biosciences, The Innovative Genomics Initiative, and Thermo Fisher Scientific.
Polaris Market Research has segmented the Europe CRISPR & Cas genes market report based on product, service, application, end use, and country:
By Product (Revenue - USD Billion, 2020–2034)
Kits & Enzymes
Vector-based Cas
DNA-free Cas
Libraries
Design Tool
Antibodies
Other Products
By Service (Revenue - USD Billion, 2020–2034)
Cell Line Engineering
gRNA Design
Microbial Gene Editing
DNA Synthesis
By Application (Revenue - USD Billion, 2020–2034)
Biomedical
Agricultural
By End Use (Revenue - USD Billion, 2020–2034)
Biotechnology & Pharmaceutical Companies
Academics & Government Research Institutes
Contract Research Organizations (CROs)
By Country Outlook (Revenue - USD Billion, 2020–2034)
Germany
UK
France
Italy
Spain
Russia
Netherlands
Rest of Europe
CRISPR-Cas genes refer to a natural bacterial defense system used for gene editing. The CRISPR sequences guide the Cas enzyme to specific DNA locations to make precise cuts.
Europe is witnessing a steady rise in demand for precision medicine, which focuses on customized treatment based on an individual’s genetic profile. CRISPR plays a critical role in enabling these personalized therapies, especially for rare genetic disorders, cancers, and inherited diseases. Healthcare systems are investing more in genetic diagnostics and targeted treatments with aging populations and increasing rates of chronic illness. European hospitals and research centers are increasingly incorporating CRISPR into clinical research and early trials. This growing focus on tailored medical solutions positions healthcare as a key application area driving CRISPR adoption across Europe.
While Europe has historically maintained strict regulations on genetic modifications, recent discussions at both national and EU levels show growing openness to gene-editing technologies such as CRISPR. Proposals for separate regulatory treatment of precision-edited organisms signal a shift toward acceptance. These evolving regulatory frameworks are crucial in reducing entry barriers for developers and encouraging investment in CRISPR research. Stakeholders gain confidence as the legal landscape becomes clearer and more favorable, especially for agricultural and medical uses.
Europe CRISPR & Cas Genes Market Report Highlights
The kits and enzymes segment is projected to register a CAGR of 18.9% during the forecast period, driven by growing adoption in pharmaceutical development, academic research, and agricultural biotechnology.
The agricultural application segment held 12.45% of the total market revenue in 2024, supported by rising demand for sustainable farming practices and innovations aimed at enhancing global food security.
In 2024, Germany contributed 23.30% to the Europe CRISPR & Cas genes market, owing to its advanced biotech infrastructure, consistent government R&D investments, and strong industry-academic partnerships.
France accounted for 15.98% of the Europe CRISPR & Cas genes market in 2024, backed by strategic funding in genomics, biotechnology advancements, and increasing focus on agricultural gene-editing research.
A few key market players are AstraZeneca, Caribou Biosciences, Inc., CRISPR Therapeutics, Danaher Corporation, Editas Medicine, Inc., Horizon Discovery Group Plc, Merck KGaA, New England BioLabs, Oxford Genetics Limited, Sherlock Biosciences, The Innovative Genomics Initiative, and Thermo Fisher Scientific.
Polaris Market Research has segmented the Europe CRISPR & Cas genes market report based on product, service, application, end use, and country:
By Product (Revenue - USD Billion, 2020–2034)
Kits & Enzymes
Vector-based Cas
DNA-free Cas
Libraries
Design Tool
Antibodies
Other Products
By Service (Revenue - USD Billion, 2020–2034)
Cell Line Engineering
gRNA Design
Microbial Gene Editing
DNA Synthesis
By Application (Revenue - USD Billion, 2020–2034)
Biomedical
Agricultural
By End Use (Revenue - USD Billion, 2020–2034)
Biotechnology & Pharmaceutical Companies
Academics & Government Research Institutes
Contract Research Organizations (CROs)
By Country Outlook (Revenue - USD Billion, 2020–2034)
Germany
UK
France
Italy
Spain
Russia
Netherlands
Rest of Europe
Table of Contents
125 Pages
- 1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
- 2. Executive Summary
- 2.1. Market Highlights
- 3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
- 4. U.S. Private 5G Network Market Insights
- 4.1. U.S. Private 5G Network Market – Market Snapshot
- 4.2. U.S. Private 5G Network Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Increasing Demand for IoT Connectivity
- 4.2.1.2. Growing Need for Low-Latency, High-Bandwidth Connectivity
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High Initial Deployment Cost and Complexity
- 4.3. Porter’s Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. U.S. Private 5G Network Market Trends
- 4.6. Value Chain Analysis
- 5. U.S. Private 5G Network Market, by Component
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. U.S. Private 5G Network Market, by Component, 2020-2034 (USD Billion)
- 5.3. Hardware
- 5.3.1. U.S. Private 5G Network Market, by Hardware, 2020-2034 (USD Billion)
- 5.3.2. Radio Access Network
- 5.3.2.1. U.S. Private 5G Network Market, by Radio Access Network, 2020-2034 (USD Billion)
- 5.3.3. Core Network
- 5.3.3.1. U.S. Private 5G Network Market, by Core Network, 2020-2034 (USD Billion)
- 5.3.4. Backhaul & Transport Interconnecting
- 5.3.4.1. U.S. Private 5G Network Market, by Backhaul & Transport Interconnecting, 2020-2034 (USD Billion)
- 5.4. Software & Services
- 5.4.1. U.S. Private 5G Network Market, by Software & Services, 2020-2034 (USD Billion)
- 5.4.2. Installation & Integration
- 5.4.2.1. U.S. Private 5G Network Market, by Installation & Integration, 2020-2034 (USD Billion)
- 5.4.3. Data Services
- 5.4.3.1. U.S. Private 5G Network Market, by Data Services, 2020-2034 (USD Billion)
- 5.4.4. Support & Maintenance
- 5.4.4.1. U.S. Private 5G Network Market, by Support & Maintenance, 2020-2034 (USD Billion)
- 6. U.S. Private 5G Network Market, by Operational Frequency
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. U.S. Private 5G Network Market, by Operational Frequency, 2020-2034 (USD Billion)
- 6.3. Sub-6GHz
- 6.3.1. U.S. Private 5G Network Market, by Sub-6GHz, 2020–2034 (USD Billion)
- 6.4. MmWave
- 6.4.1. U.S. Private 5G Network Market, by MmWave, 2020–2034 (USD Billion)
- 7. U.S. Private 5G Network Market, by Spectrum
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. U.S. Private 5G Network Market, by Spectrum, 2020-2034 (USD Billion)
- 7.3. Licensed
- 7.3.1. U.S. Private 5G Network Market, by Licensed, 2020–2034 (USD Billion)
- 7.4. Unlicensed/Shared
- 7.4.1. U.S. Private 5G Network Market, by Unlicensed/Shared, 2020–2034 (USD Billion)
- 8. U.S. Private 5G Network Market, by Vertical
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. U.S. Private 5G Network Market, by Vertical, 2020-2034 (USD Billion)
- 8.3. Manufacturing
- 8.3.1. U.S. Private 5G Network Market, by Manufacturing, 2020-2034 (USD Billion)
- 8.4. Food & Beverages
- 8.4.1. U.S. Private 5G Network Market, by Food & Beverages, 2020-2034 (USD Billion)
- 8.4.2. Automotive
- 8.4.2.1. U.S. Private 5G Network Market, by Automotive, 2020-2034 (USD Billion)
- 8.4.3. Pharmaceuticals
- 8.4.3.1. U.S. Private 5G Network Market, by Pharmaceuticals, 2020-2034 (USD Billion)
- 8.4.4. Electrical & Electronics
- 8.4.4.1. U.S. Private 5G Network Market, by Electrical & Electronics, 2020-2034 (USD Billion)
- 8.4.5. Heavy Machinery
- 8.4.5.1. U.S. Private 5G Network Market, by Heavy Machinery, 2020-2034 (USD Billion)
- 8.4.6. Clothing & Accessories
- 8.4.6.1. U.S. Private 5G Network Market, by Food & Beverages, 2020-2034 (USD Billion)
- 8.4.7. Other Manufacturing Verticals
- 8.4.7.1. U.S. Private 5G Network Market, by Other Manufacturing Verticals, 2020-2034 (USD Billion)
- 8.5. Energy & Utilities
- 8.5.1. U.S. Private 5G Network Market, by Energy & Utilities, 2020-2034 (USD Billion)
- 8.6. Transportation & Logistics
- 8.6.1. U.S. Private 5G Network Market, by Transportation & Logistics, 2020-2034 (USD Billion)
- 8.7. Aerospace & Defense
- 8.7.1. U.S. Private 5G Network Market, by Aerospace & Defense, 2020-2034 (USD Billion)
- 8.7.2. Government & Public Safety
- 8.7.2.1. U.S. Private 5G Network Market, by Government & Public Safety, 2020-2034 (USD Billion)
- 8.7.3. Corporates/Enterprises
- 8.7.4. U.S. Private 5G Network Market, by Food & Beverages, 2020-2034 (USD Billion)
- 8.7.5. Mining
- 8.7.5.1. U.S. Private 5G Network Market, by Mining, 2020-2034 (USD Billion)
- 8.7.6. Healthcare
- 8.7.6.1. U.S. Private 5G Network Market, by Healthcare, 2020-2034 (USD Billion)
- 8.7.7. Oil & Gas
- 8.7.7.1. U.S. Private 5G Network Market, by Oil & Gas, 2020-2034 (USD Billion)
- 8.7.8. Others
- 8.7.8.1. U.S. Private 5G Network Market, by Others, 2020-2034 (USD Billion)
- 9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
- 10. Company Profiles
- 10.1. Amazon Web Services, Inc.
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
- 10.2. AT&T
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
- 10.3. Betacom Inc
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
- 10.4. Boingo Wireless, Inc.
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
- 10.5. CELONA INC.
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
- 10.6. Federated Wireless
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
- 10.7. KORE Wireless
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
- 10.8. Microsoft (Azure Private 5G)
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
- 10.9. T‑Mobile USA, Inc.
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
- 10.10. Verizon
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.